NCT05909163View on ClinicalTrials.gov

Spoken Discourse Biomarker of PD Cognitive Impairment

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

March 5, 2019

Primary Completion Date

February 15, 2023

Study Completion Date

February 15, 2023

Conditions
Parkinson Disease
Trial Locations (1)

60201

Northwestern University, Evanston

All Listed Sponsors
lead

Northwestern University

OTHER

NCT05909163 - Spoken Discourse Biomarker of PD Cognitive Impairment | Biotech Hunter | Biotech Hunter